APTV.NYSEAptiv PLC

Form 4: Aptiv PLC Executive Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Joseph R. Massaro, Vice Chairman of ECG at Aptiv PLC, reports transactions involving ordinary shares, including disposals due to below-target performance and tax liabilities, as well as acquisitions related to vesting and performance shares.

Summary

  • On February 28, 2025, Joseph R. Massaro, Vice Chairman of ECG at Aptiv PLC, reported changes in his beneficial ownership of Aptiv PLC ordinary shares.
  • He disposed of 8,010 shares back to the issuer due to below-target performance during the 2022-2024 performance period.
  • Additionally, 16,068 shares were withheld to cover tax liabilities from the vesting of restricted stock units at a price of $65.12.
  • Massaro also acquired 37,527 shares that will vest in three equal installments beginning on the first anniversary of the grant date.
  • He acquired 79,556 performance shares, which represent a contingent right to receive ordinary shares based on performance criteria from January 1, 2025, to December 31, 2027.
  • Following these transactions, Massaro beneficially owns 364,392 ordinary shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While there's a disposal of shares due to underperformance, there are also acquisitions of shares, indicating continued investment. The overall impact is balanced.

Positives

  • The acquisition of 37,527 shares indicates a continued investment in the company's future.
  • The acquisition of 79,556 performance shares suggests confidence in achieving future performance targets.

Negatives

  • The disposal of 8,010 shares due to below-target performance in 2022-2024 could be seen as a negative signal, although it is related to a specific performance period.
  • The withholding of 16,068 shares for tax liabilities, while a normal occurrence, reduces the executive's overall shareholding.

Risks

  • The vesting of performance shares is contingent on achieving specified performance criteria, which introduces uncertainty.
  • Future performance may not meet the targets required for the performance shares to vest fully.

Future Outlook

The vesting of performance shares is contingent upon the achievement of specified performance criteria between January 1, 2025 and December 31, 2027.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's confidence in the company's prospects.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and their executives.
  • The vesting schedules and performance-based equity awards are common compensation practices in the industry, similar to those at companies like Delphi Technologies and Visteon.

Stakeholder Impact

  • Shareholders may interpret the transactions as a reflection of management's view on the company's performance and future prospects.
  • Employees holding similar equity awards may be affected by the performance criteria associated with the vesting of shares.

Key Dates

DateDescription
2022-2024Performance period for which below-target performance led to share disposal.
02/28/2025Date of the reported transactions.
03/04/2025Date of signature on the Form 4 filing.
January 1, 2025Start date of the performance period for performance shares.
December 31, 2027End date of the performance period for performance shares.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.